Document: Medicinal products for human use: monthly figures - November 2025-2025/12/8

Document: Deadlines for submission of applications for orphan medicinal product designation to the EMA and corresponding COMP timetable for valid applications 2026-2027-2026/1/19

Page: Risk management requirements for elemental impurities in veterinary medicinal products - Scientific guideline-2026/2/20

Document: QRD Appendix V - Adverse-drug-reaction reporting details-2026/3/25

Document: List of eligible industry stakeholder organisations-2026/5/4

Page: Contacting EMA: post-authorisation-2026/6/15

Document: Guideline on data requirements for changes to the strain composition of authorised equine influenza vaccines in line with WOAH recommendations - Revision 1-2026/7/24

In Vitro Release Test Studies for Topical Drug Products Submitted in ANDAs (Draft)-2022/10/21

国家药监局药审中心关于发布《儿童用药沟通交流中Ⅰ类会议申请及管理工作细则（试行）》的通告-2023/4/18

Scientific guideline: Guideline on the calculation of dose factor to be submitted to the Union Product Database (UPD)-2023/10/13